2nd Quarter - Report
TIBER CREEK HEALTH STRATEGIES, INC. for AMGEN, INC.
Client
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issue related to implementation of drug pricing and reimbursement for prescription drugs in the Inflation Reduction Act of 2022 (PL 117-169).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES BRYANT HALL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.